Metropolitan Life Insurance CO Alpine Immune Sciences, Inc. Transaction History

Metropolitan Life Insurance CO

  • $253 Million
  • Q2 2024

Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

May 14, 2024
BUY
$17.75 - $41.6 $5,041 - $11,814
284 Added 16.29%
2,027 $80,000
Q2 2023

Aug 10, 2023
BUY
$6.84 - $11.91 $8,249 - $14,363
1,206 Added 224.58%
1,743 $17,000
Q1 2023

May 15, 2023
SELL
$7.0 - $8.75 $6,167 - $7,708
-881 Reduced 62.13%
537 $4,000
Q4 2022

Jun 14, 2023
BUY
$5.45 - $7.35 $4,801 - $6,475
881 Added 164.06%
1,418 $10.4 Million
Q4 2022

Feb 15, 2023
BUY
$5.45 - $7.35 $7,728 - $10,422
1,418 New
1,418 $10,000

Others Institutions Holding ALPN

# of Institutions
2
Shares Held
56.2K
Call Options Held
0
Put Options Held
0
View Full List

About ALPINE IMMUNE SCIENCES, INC.

ALPN Quotes by TradingView
  • Ticker ALPN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 44,006,700
  • Description
  • Alpine Immune Sciences, Inc., a clinical-stage biopharmaceutical company, focuses on the discovery and development of protein-based immunotherapies for the treatment of cancer, autoimmune/inflammatory disorders, and other diseases. Its product pipeline includes ALPN-101, an inducible T cell costimulator (ICOS)/cluster of differentiation 28 (CD28...
More about ALPN
Track This Portfolio

Track Metropolitan Life Insurance CO Portfolio

Follow Metropolitan Life Insurance CO and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Metropolitan Life Insurance CO, based on Form 13F filings with the SEC.

News

Stay updated on Metropolitan Life Insurance CO with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email